The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I dose-escalation study of desynchronized irinotecan plus bevacizumab, oxaliplatin, 5-fluorouracil, and folinic acid (bFOLFIRINOX-3) administration in chemorefractory metastatic colorectal cancer patients.
 
Jean-David Fumet
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer
 
Alice Hervieu
Travel, Accommodations, Expenses - Novartis
 
Audrey Hennequin
No Relationships to Disclose
 
Sylvie Zanetta
No Relationships to Disclose
 
Aurelie Bertaut
No Relationships to Disclose
 
François Ghiringhelli
Honoraria - Enterome; MSD; Roche; Sanofi
Consulting or Advisory Role - Enterome; Roche
Travel, Accommodations, Expenses - Amgen; Roche